Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adenophora triphylla root ethanol extract (ATREE) is a botanical extract derived from the roots of the perennial herb *Adenophora triphylla*. It has been studied primarily for its potential therapeutic effects in metabolic disorders, specifically obesity. Preclinical research in murine models indicates that ATREE exerts anti-obesity effects by modulating key metabolic and inflammatory pathways. Specifically, it has been shown to activate AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-α) signaling, while simultaneously downregulating the expression of adipogenic markers such as peroxisome proliferator-activated receptor gamma (PPAR-γ) and glycerol-3-phosphate dehydrogenase (GPDH). Additionally, ATREE exhibits antioxidant and anti-inflammatory properties, reducing levels of tumor necrosis factor-alpha (TNF-α) and increasing adiponectin expression, which suggests a role in mitigating oxidative stress and inflammation associated with high-fat diets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adenophora triphylla root ethanol extract.